• Image
  • Image
  • Image

Why Partner with Galderma

Backed by dermatology company Galderma’s financial strength and stability, and that of our shareholders, Nestlé and L’Oréal, your product will have the necessary support to realize its true potential. We are well-positioned to secure and dedicate resources to the right opportunities.  

At Galderma, we understand the value of partnerships and our commitment is to build strong working relationships with our partners. As part of that commitment, we created Alliance Management, a group of professionals dedicated to streamlining the business and contractual aspects of our partnerships.

Alliance Management representatives work with team members across all functions from both Galderma and our partners to establish project objectives and decision-making. As the point of contact for contract and business issues, Alliance Management helps identify and resolve issues that might otherwise strain the relationship. Through the duration of the partnership, the Alliance Management team also helps identify and resolve strategic opportunities and issues for the program. 

We believe in:

  • Complete trust and mutual respect, 

  • Success-oriented cooperation,

  • Flexibility in achieving common goals,

  • Proactive alliance management,

  • A customized approach to each partnership – there is no “standard” deal.

 

 Product

Transaction date

 Indication

 Pliaglis

 2007

 Topical anesthetic

 BTX-A product

 2007

 Botulinum toxin Type A

 Clobex Spray

 2005

 Psoriasis

 Metvix

 2002

 Skin cancer

 Rosanil

 2001

 Rosacea

 Clobex

 2000

 Psoriasis

 Clindagel

 1998

 Acne

 Loceryl

 1998

 Onychomycosis

 Tri-Luma

 1997

 Melasma

 Silkis

 1996

 Psoriasis

 MetroGel / Rozex

 1993

 Rosacea



Contact Galderma today to discuss the potential for your drug candidate in dermatology.

 

Working together

Backed by Galderma’s financial strength and stability, and that of our shareholders, Nestlé and L’Oréal, your product will have the necessary support to realize its true potential. We are well-positioned to secure and dedicate resources to the right opportunities.

Yet financial stability alone is not enough. The success of your opportunity also depends on a strong infrastructure which dermatology company Galderma can provide. Our research expertise is backed by development capabilities in many countries around the world. Galderma moves quickly to evaluate the potential of a compound in human studies and conducts definitive clinical trials with clearly-defined endpoints for those compounds that advance. We offer the benefit of years of experience with the U.S. Food and Drug Administration and other regulatory authorities around the world. Our state-of-the-art production facilities and our experienced manufacturing staff can expedite your product’s launch. Dermatology company Galderma is also able to provide the commercialization experience necessary for a successful launch. 

Contact Information

Follow us Follow us on twitter Follow us on Linkedin

Corporate responsibility

Growing a responsible dermatological community

Discover some of the positive initiatives we are involved in across the world

Read

Video

We are committed

See all videos